Book a demo

Industry

Five challenges facing Indian pharma manufacturers, and how Formezy ERP helps

Illustration of a pharmaceutical plant control room with batch dashboards

Indian pharmaceutical manufacturing covers everything from large API plants to small nutraceutical, veterinary and Ayurvedic units. The products differ, but the problems plant heads describe are remarkably similar. Here are the five that come up most often, and what an ERP should record to help with each.

1. Rising expectations for records

The revised Schedule M, notified on 28 December 2023, moved Indian good manufacturing practice closer to international standards such as WHO-GMP. In practice, that means more attention to how materials, batches, equipment and quality decisions are documented, and less tolerance for records compiled after the event.

An ERP cannot make a plant compliant; that depends on the whole quality system. What it can do is capture the data as work happens: material status at receipt, quantities at dispensing, stages and in-process results during the batch, and release decisions at the end. Formezy records each of these against the batch, with an audit trail of changes, so the records exist before anyone asks for them.

2. Materials used before they are approved

In a busy plant, a lot can be issued before QC has finished testing it, simply because a label was not changed. The fix is to hold status in the system, not on a sticker. In Formezy every lot carries a status from the goods receipt: Quarantine, Under test, Approved or Rejected. Dispensing and issue screens only offer approved lots. The same idea applies to finished goods: only released batches can be invoiced or dispatched.

3. Yields nobody can explain

Many plants know their monthly yield but not where the losses happen. Is it in the reaction, the centrifuge, the dryer, the mill or the packing line? Without stage-wise figures, every discussion turns into guesswork.

When input and output are booked at every stage, yield can be calculated per stage and per batch. Formezy does this from the quantities recorded at dispensing and at each stage, and compares them with the theoretical yield, so a batch that lost more than usual stands out while it is still being reviewed. See how this works on the bulk drug manufacturing ERP page, or in our guide to BMR/BPR and batch costing.

4. Expiry and retest dates

APIs and many raw materials carry retest dates; finished products carry expiry dates. When these dates live in a spreadsheet, stock expires on the shelf and retests are missed. The answer is to store the dates on each lot and issue stock first-expiry-first-out.

Formezy keeps manufacturing, expiry and retest dates on every lot and batch, suggests lots in FEFO order at issue and picking, and flags stock approaching its dates. Our guide to expiry, retest and FEFO management explains the approach in more detail.

5. Traceability under pressure

When a supplier issues a notice about a material lot, or a customer complains about a batch, the question is always the same: which batches used it, and who received them? Rebuilding that chain from registers can take days.

In Formezy, the chain is built as work happens. The goods receipt creates the lot, dispensing links it to the batch, each stage links intermediates to their inputs, and dispatch records batch and quantity on every invoice. A forward or backward trace is one search. See pharma batch traceability for how it works.

Where to start

Most plants do not need to fix all five problems at once. A common path is to start with goods receipt, material status and dispensing, because they underpin everything else, then add batch stages, QC release and dispatch. Each step makes the next one easier, because the data is already there.

If you would like to see how this looks on your own process, book a demo and we will walk through your plant step by step.

See Formezy on your own process

Book a demo tailored to your segment.

CallWhatsAppBook a demo
Chat